These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23018618)

  • 1. Synergistic effects of photodynamic therapy with HPPH and gemcitabine in pancreatic cancer cell lines.
    Sun G; Anderson MA; Gorospe EC; Leggett CL; Lutzke LS; Wong Kee Song LM; Levy M; Wang KK
    Lasers Surg Med; 2012 Nov; 44(9):755-61. PubMed ID: 23018618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: implications for photodynamic therapy.
    Lobel J; MacDonald IJ; Ciesielski MJ; Barone T; Potter WR; Pollina J; Plunkett RJ; Fenstermaker RA; Dougherty TJ
    Lasers Surg Med; 2001; 29(5):397-405. PubMed ID: 11891727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with Barrett's esophagus.
    Nava HR; Allamaneni SS; Dougherty TJ; Cooper MT; Tan W; Wilding G; Henderson BW
    Lasers Surg Med; 2011 Sep; 43(7):705-12. PubMed ID: 22057498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines.
    Celli JP; Solban N; Liang A; Pereira SP; Hasan T
    Lasers Surg Med; 2011 Sep; 43(7):565-74. PubMed ID: 22057484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization and treatment of transformed tissues using the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a.
    Furukawa K; Yamamoto H; Crean DH; Kato H; Mang TS
    Lasers Surg Med; 1996; 18(2):157-66. PubMed ID: 8833284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel methods to incorporate photosensitizers into nanocarriers for cancer treatment by photodynamic therapy.
    Wang S; Fan W; Kim G; Hah HJ; Lee YE; Kopelman R; Ethirajan M; Gupta A; Goswami LN; Pera P; Morgan J; Pandey RK
    Lasers Surg Med; 2011 Sep; 43(7):686-95. PubMed ID: 22057496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the 2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide (HPPH) mediated photodynamic therapy by macroscopic singlet oxygen modeling.
    Penjweini R; Kim MM; Liu B; Zhu TC
    J Biophotonics; 2016 Dec; 9(11-12):1344-1354. PubMed ID: 27653233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
    Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Pandey RK; Tsuchida T; Dougherty TJ
    Cancer Res; 2003 Apr; 63(8):1806-13. PubMed ID: 12702566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.
    Seshadri M; Spernyak JA; Mazurchuk R; Camacho SH; Oseroff AR; Cheney RT; Bellnier DA
    Clin Cancer Res; 2005 Jun; 11(11):4241-50. PubMed ID: 15930363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy with 3-(1'-hexyloxyethyl) pyropheophorbide a for cancer of the oral cavity.
    Rigual N; Shafirstein G; Cooper MT; Baumann H; Bellnier DA; Sunar U; Tracy EC; Rohrbach DJ; Wilding G; Tan W; Sullivan M; Merzianu M; Henderson BW
    Clin Cancer Res; 2013 Dec; 19(23):6605-13. PubMed ID: 24088736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergetic anticancer effect of combined gemcitabine and photodynamic therapy on pancreatic cancer in vivo.
    Xie Q; Jia L; Liu YH; Wei CG
    World J Gastroenterol; 2009 Feb; 15(6):737-41. PubMed ID: 19222100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a in photodynamic therapy of human esophageal squamous cancer cells.
    Wu D; Liu Z; Fu Y; Zhang Y; Tang N; Wang Q; Tao L
    Oncol Lett; 2013 Oct; 6(4):1111-1119. PubMed ID: 24137473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase I Study of Light Dose for Photodynamic Therapy Using 2-[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a for the Treatment of Non-Small Cell Carcinoma In Situ or Non-Small Cell Microinvasive Bronchogenic Carcinoma: A Dose Ranging Study.
    Dhillon SS; Demmy TL; Yendamuri S; Loewen G; Nwogu C; Cooper M; Henderson BW
    J Thorac Oncol; 2016 Feb; 11(2):234-41. PubMed ID: 26718878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and application of a physiologically based pharmacokinetic model for HPPH in rats and extrapolate to humans.
    Chen L; Zhang X; Cao Q; Wu Y; Zhang T; Tong H; Wang X; Yang J
    Eur J Pharm Sci; 2019 Mar; 129():68-78. PubMed ID: 30597205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesoscopic fluorescence tomography of a photosensitizer (HPPH) 3D biodistribution in skin cancer.
    Ozturk MS; Rohrbach D; Sunar U; Intes X
    Acad Radiol; 2014 Feb; 21(2):271-80. PubMed ID: 24439340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effects of deuterium oxide and gemcitabine in human pancreatic cancer cell lines.
    Bader Y; Hartmann J; Horvath Z; Saiko P; Grusch M; Madlener S; Maier S; Oehler L; Fritzer-Szekeres M; Heller N; Alken RG; Krupitza G; Szekeres T
    Cancer Lett; 2008 Feb; 259(2):231-9. PubMed ID: 18023527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gap junction enhances phototoxicity of photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinylpyropheophorbide-a (HPPH).
    Liu Z; Wang Q; Fan L; Wu DP; Zhang Y; Liu L; Tao L
    Lasers Surg Med; 2015 Jan; 47(1):68-76. PubMed ID: 25483871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic cancer cell genetics and signaling response to treatment correlate with efficacy of gemcitabine-based molecular targeting strategies.
    Holcomb B; Yip-Schneider MT; Matos JM; Dixon J; Kennard J; Mahomed J; Shanmugam R; Sebolt-Leopold J; Schmidt CM
    J Gastrointest Surg; 2008 Feb; 12(2):288-96. PubMed ID: 18049840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjugation of cRGD peptide to chlorophyll a based photosensitizer (HPPH) alters its pharmacokinetics with enhanced tumor-imaging and photosensitizing (PDT) efficacy.
    Srivatsan A; Ethirajan M; Pandey SK; Dubey S; Zheng X; Liu TH; Shibata M; Missert J; Morgan J; Pandey RK
    Mol Pharm; 2011 Aug; 8(4):1186-97. PubMed ID: 21702452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verteporfin- and sodium porfimer-mediated photodynamic therapy enhances pancreatic cancer cell death without activating stromal cells in the microenvironment.
    Lu J; Roy B; Anderson M; Leggett CL; Levy MJ; Pogue B; Hasan T; Wang KK
    J Biomed Opt; 2019 Nov; 24(11):1-11. PubMed ID: 31741351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.